Analyst Ratings For NASDAQ:BGNE – BeiGene (NASDAQ:BGNE)
Today, Maxim Group raised its price target on NASDAQ:BGNE – BeiGene (NASDAQ:BGNE) to $200.00 per share.
Some recent analyst ratings include
- 3/1/2018-Robert W. Baird Reiterated Rating of Hold.
- 3/1/2018-Ladenburg Thalmann Reiterated Rating of Buy.
- 1/8/2018-Cowen Reiterated Rating of Buy.
- 8/15/2017-Goldman Sachs Reiterated Rating of Buy.
- 6/1/2017-William Blair Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:BGNE – BeiGene (NASDAQ:BGNE)
NASDAQ:BGNE – BeiGene (NASDAQ:BGNE) has insider ownership of 19.90% and institutional ownership of 51.47%.
- On 3/19/2018 Howard Liang, CFO, sold 40,000 with an average share price of $160.27 per share and the total transaction amounting to $6,410,800.00.
- On 3/16/2018 Howard Liang, CFO, sold 10,872 with an average share price of $157.07 per share and the total transaction amounting to $1,707,665.04.
- On 3/2/2018 John Oyler, CEO, sold 99,000 with an average share price of $145.63 per share and the total transaction amounting to $14,417,370.00.
- On 2/28/2018 Ji Li, EVP, sold 10,000 with an average share price of $146.88 per share and the total transaction amounting to $1,468,800.00.
- On 2/28/2018 John Oyler, CEO, sold 34,338 with an average share price of $146.69 per share and the total transaction amounting to $5,037,041.22.
- On 1/18/2018 Bros. Advisors Lp Baker, Director, bought 1,980,198 with an average share price of $101.00 per share and the total transaction amounting to $199,999,998.00.
- On 12/26/2017 John Oyler, CEO, sold 20,137 with an average share price of $96.46 per share and the total transaction amounting to $1,942,415.02.
Recent Trading Activity for NASDAQ:BGNE – BeiGene (NASDAQ:BGNE)
Shares of NASDAQ:BGNE – BeiGene closed the previous trading session at 173.00 up +6.77 4.07% with shares trading hands.